Form SC 14F1 - Statement regarding change in majority of directors [Rule 14f-1]:
SEC Accession No. 0001193125-04-062448
Filing Date
2004-04-15
Accepted
2004-04-14 17:56:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 INFORMATION STATEMENT dsc14f1.htm SC 14F1 120292
  Complete submission text file 0001193125-04-062448.txt   122724
Mailing Address 6040 N CUTTER CIRCLE STE 317 PORTLAND OR 97217
Business Address 6040 N CUTTER CIRCLE STE 317 PORTLAND OR 97217 5032833911
OXIS INTERNATIONAL INC (Filed by) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6040 N CUTTER CIRCLE STE 317 PORTLAND OR 97217
Business Address 6040 N CUTTER CIRCLE STE 317 PORTLAND OR 97217 5032833911
OXIS INTERNATIONAL INC (Subject) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14F1 | Act: 34 | File No.: 005-32837 | Film No.: 04734247
SIC: 2834 Pharmaceutical Preparations